Share your thoughts on this presentation with #IAS2019

Slides:



Advertisements
Similar presentations
Impact of Tryptophan Catabolism on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART Peter W. Hunt, Sheri Weiser, Yong Huang,
Advertisements

Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Should we treat HIV Controllers ? IAS 2013 Pr Olivier Lambotte Department of internal medicine and clinical immunology Bicêtre Hospital, University Paris.
Main questions on HIV persistence and on obstacles to HIV eradication Jean-Pierre Routy M.D. McGill University Montreal Toward an HIV cure: Insight into.
The pathogenesis of persistent HIV-associated inflammation during long-term antiretroviral therapy Steven G. Deeks Professor of Medicine University of.
Memory CCR6+CD4+ T-Cells are Selectively Imprinted with a Transcriptional Program Favorable to Productive HIV-1 Infection Patricia Monteiro, Jean-Philippe.
Protective HLA Class I alleles are associated with reduced immune activation in Primary HIV infection Elizabeth Hamlyn 1, Stephen Hickling 2, Abdel Babiker.
Slide 1 of 24 From DC Douek, MD, at San Francisco, CA: March 24, 2013, IAS-USA. IAS–USA Daniel C. Douek, MD, PhD Bethesda, Maryland Immune Activation,
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial James Williams 1,2,3, Jacob Hurst 1,2,3,
DNA methylation as an epigenetic marker in HIV-2 disease in West Africa? Alberta Davis MRC Laboratories, Gambia 18th January 2013.
Slide 1 of 10 From DC Douek, MD, at Atlanta, GA: April 10, 2013, IAS-USA. IAS–USA Daniel C. Douek, MD, PhD Bethesda, Maryland Immune Activation, HIV Persistence,
Myeloid cells matter Conclusions. Glut1+ CD14++ CD16+ Associated with inflammatory markers HIV Immune activation HIV-related diseases Joshua Anzigen:
Rémi Cheynier Victor Appay Anne Hosmalin Gianfranco Pancino Vincent Vieillard Brigitte Autran Françoise Brun-Vezinet Charlotte Charpentier Diane Descamps.
Long-term ART initiated during primary HIV-1 infection limits the HIV-1 reservoir size but not to levels found in LTNPs Eva Malatinkova, Ward De Spiegelaere,
Antibody and B cell responses may control circulating lipopolysaccharide in patients with HIV infection Lim A 1, Amini A 1, D’Orsogna L 2, Rajasuriar R.
Novel Approaches: Treatment and HIV Pathogenesis L. Trautmann, Ph.D. VGTI Florida.
Naive CD4 T lymphocytes and recent thymic emigrants, 15 or more years after perinatal HIV infection The ANRS-EP38-IMMIP study Stéphane Blanche, Daniel.
T-Cell Senescence & Inflammation HIV Research Catalyst Forum, April
HIV-1 infected subjects treated with an autologous dendritic cell therapy (AGS-004), exhibited a significant reduction in viral load (when compared to.
The Role of TCR gamma-delta T cells in Celiac Disease Columbia University, College of Physicians and Surgeons By: Nertila Ujkaj Littin Kandoth Sandra.
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
The only end-points of therapy that matter are mucosal healing, normal blood work, and negative radiologic studies. Robert N. Baldassano, MD Colman Family.
Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.
What are possible biomarkers for cure-related interventions ? Lars Ostergaard, MD, Ph.D., DMSc Prof/Head Dept of infectious diseases Aarhus.
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
SERUM CYTOKINE PATTERNS IN CELIAC DISEASE Shabab Naqvi & Ibrahim Ibrahim Mentor: Dr. Sanil Manavalan Columbia University, College of Physicians and Surgeons.
Immune reconstitution Anjie Zhen, PhD
Lecture 7 Immunology Cells of adaptive immunity
Routine vaccination and maintenance of serological memory in HIV infected children Moderators: Berhanu Gudeta, Ethiopia Francesca Chiodi, Sweden Cell Damage.
HIV ‐ 1 replication activates CD4 + T cells with specificities for persistent herpes viruses by Anna Haas, Manuela Rehr, Frederik Graw, Peter Rusert, Walter.
Background  HIV-1 infection persists in reservoirs and leads to progressive depletion of CD4+ T-cells even in subjects with slow disease progression 
#AIDS2016 HIV Persists in Colon and Blood CCR6+ T-Cells During Viral Suppressive ART Jean-Pierre Routy on behalf of : A. Gosselin, T.
Michael Imbeault, Dave Bélanger, Michel Ouellet,
IMMUNE RESPONSE AT MUCOSAL SURFACES
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
Celiac Disease: An Immunological Jigsaw
Confounding factors and choice of controls in studies of immune activation and inflammation Caroline Sabin.
Chronic immune activation in HIV associated Non Hodgkin lymphoma and the effect of antiretroviral therapy Brian Flepisi University of the Western Cape.
Engagement in methadone maintenance therapy associated with less time with plasma HIV-1 RNA viral load above 1500 copies/mL among a cohort of HIV-positive.
Coinfection With HIV-1 and HCV—A One-Two Punch
The Aging Liver in the Aging HIV and HCV Patients
Volume 148, Issue 1, Pages (January 2015)
Acute Graft-versus-Host Disease: Novel Biological Insights
Volume 130, Issue 1, Pages (January 2006)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Herbert Tilg, Timon E. Adolph  Cell Metabolism 
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
J. P. Routy1, V. Mehraj1,, R. Ramendra1,, C. Costiniuk1,, B
Follicular CD8+ T-cells (fCD8) in GALT are associated with lower HIV-1 reservoir in the terminal ileum after ART initiated during PHI John Thornhill Imperial.
Gluten and IgA nephropathy: you are what you eat?
Gut Microbiota: Mining for Therapeutic Potential
Steven G. Deeks, Russell Tracy, Daniel C. Douek  Immunity 
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights
Residual Disease and Immune Activation/Inflammation on ART
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Pro-inflammatory and anti-inflammatory effects of the gut microbiota Figure 2 | Pro-inflammatory and anti-inflammatory effects of the gut microbiota.
Volume 141, Issue 4, Pages e3 (October 2011)
Marta Wlodarska, Aleksandar D. Kostic, Ramnik J. Xavier 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Coinfection With HIV-1 and HCV—A One-Two Punch
Robyn S. Klein, Christopher A. Hunter  Immunity 
Volume 21, Issue 6, Pages (December 2004)
hypothesis hypothesis days post SIV infection cynomolgus macaques rhesus macaques 16S rDNA copies/ml days post SIV infection.
Schematic diagrams of small intestine mucosa in normal and infected intestines. Schematic diagrams of small intestine mucosa in normal and infected intestines.
Steven G. Deeks, Russell Tracy, Daniel C. Douek  Immunity 
Share your thoughts on this presentation with #IAS2019
Inflammation process and possible routes of probiotic action in the maintenance of CD. In CD patients, increased epithelial tight junction permeability.
Presentation transcript:

Share your thoughts on this presentation with #IAS2019 Relevance of REG3a and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIV Stéphane Isnard, Rayoun Ramendra, Franck P. Dupuy, John Lin, Brandon Fombuena, Nikola Kokinov, Ido Kema, Mohammad-Ali Jenabian, Bertrand Lebouché, Cecilia T. Costiniuk, Petronela Ancuta, Nicole F. Bernard, Michael S. Silverman, Peter L. Lakatos, Madeleine Durand, Cécile Tremblay, Jean-Pierre Routy McGill university, Canada Share your thoughts on this presentation with #IAS2019

No conflict of interest

Gut permeability vs. gut damage REG3a C-type lectin acting as an antimicrobial peptide Constitutively produced and secreted in the gut lumen by Paneth cells Translocate in the mucosa then blood only upon loss of epithelial cells-to-cell interaction Circulating levels are elevated in GVHD, Coeliac and Crohn’s disease, ulcerative colitis  Marker of gut permeability I-FABP Intracellular protein only expressed by enterocytes Found in the mucosa and blood upon enterocyte cell-death Circulating levels are elevated in enteropathies and people with chronic HIV infection.  Marker of gut epithelial damage Regenerating islet-derived protein-3α Intestinal fatty acid binding protein REG3a I-FABP I-FABP I-FABP I-FABP REG3a Major-Monfried et al. Blood 2018 Zhao et al. J Clin Invest 2018 Marafini et al. Aliment Pharmacol Ther 2014 Cheru et al. Op Forum Inf Dis 2018

Plasma REG3a levels are elevated in PLWH, including elite controllers Plasma levels of REG3a, but not I-FABP, decreased with ART.

Association between REG3a and I-FABP with different HIV and inflammation markers Parameter REG3α I-FABP Disease Progression CD4 T-cell count r=-0.28 p=0.0003 n=161 r=-0.07 p=0.4 n=160 CD8 T-cell Count r=-0.006 p=0.9 r=0.11 p=0.2 CD4/CD8 r=-0.29 p=0.0002 r=-0.35 p=0.7 Viral Load r=0.29 p=0.01 n=72 r=0.002 p=0.99 Parameter REG3α I-FABP Microbial translocation, gut inflammation LPS r=0.24 p=0.005 n=139 r=0.047 p=0.6 n=160 βDG r=0.19 p=0.03 r=0.11 p=0.2 sCD14 r=0.37 p=0.001 n=74 r=-0.0012 p=0.99 n=83 Tryptophan r=-0.41 p=0.0001 n=81 r=-0.031 p=0.8 n=87 Kynurenine r=0.30 p=0.006 p=0.12 r=0.3 n=88 Kyn/Trp r=0.39 p=0.0003 r=0.12 p=0.3 Parameter REG3α I-FABP Inflammation, immune activation IL-6 r=0.53 p<0.0001 n=139 r=0.11 p=0.2 n=160 IL-8 r=0.51 n=190 r=0.17 p=0.04 IgG r=0.44 p=0.002 n=47 r=0.16 p=0.3 n=49 IgM r=0.2 r=-0.081 p=0.6 IgA r=-0.12 p=0.4 n=50 r=0.005 p=0.99 n=52 spearman correlations

Plasma REG3a but not I-FABP levels are associated with integrated HIV DNA in CD4 T-cells EHI ART- CHI ART- CHI ART+ EC

Thanks to all study participants Acknowledgments Poster TUPDA0103 Drs JG Baril, B Lessard, MA Charron, S Dufresne, ME Turgeon, S Vézina, E Huchet, JP Kerba, M Poliquin, S Poulin, P Rochette, P Junod, D Longpré, R Pilarski, E Sasseville, L Charest, A Hamel, A Cloutier-Blais, S Massoud, F Chano, B Trottier McGill University Health Centre Dr Jean-Pierre Routy Rayoun Ramendra Dr Franck P Dupuy Dr Vikram Mehraj John Lin Josée Girouard Angie Massicotte Brandon Fombuena CVIS Drs C Costiniuk, B Lebouché, A de Pokomandy, J Szabo, J Cox, LP Haraoui, M Klein Dr P Ancuta Dr N Chomont Dr C Tremblay Dr M Durand, Dr C Chartrand-Lefebvre Rejean Thomas Dr R Leblanc Montreal Primary HIV-infection cohort Canadian HIV infected Slow Progressors Canadian HIV and Aging Cohort Scholarship Thanks to all study participants 7